Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Dayu Lv"'
Publikováno v:
Computer methods and programs in biomedicine. 211
Background and objective: Glycemic control, especially meal-related disturbance rejection, has proven to be a major challenge for people with type 1 diabetes. In this manuscript, we introduce a novel, personalized, advanced hybrid insulin infusion sy
Autor:
Ananda Basu, Michele Schiavon, Tyler Jean, Steve Patek, Alejandro J. Laguna Sanz, Mei Mei Church, Jordan E. Pinsker, Boris Kovatchev, Ling Hinshaw, Vikash Dadlani, Stacey M. Anderson, Francis J. Doyle, Wendy C. Bevier, Shelly K. McCrady-Spitzer, Elaine Schertz, Rickey E. Carter, Yogish C. Kudva, Dayu Lv, Paige K. Bradley, Emma Emory, Claudio Cobelli, Chiara Dalla Man, Ravi Gondhalekar, Jonathan Hughes, Eyal Dassau, Isuru Dasanayake, Lauren M. Huyett, Sue A. Brown
Publikováno v:
Diabetes Care. 40:1719-1726
OBJECTIVE Artificial pancreas (AP) systems are best positioned for optimal treatment of type 1 diabetes (T1D) and are currently being tested in outpatient clinical trials. Our consortium developed and tested a novel adaptive AP in an outpatient, sing
Publikováno v:
IFAC-PapersOnLine. 49:773-778
This paper develops a novel approach to data-driven optimization of insulin pump treatment parameters in Type 1 Diabetes (T1D). In this approach, records of continuous glucose monitoring (CGM), insulin delivery, and meal records are used (i) to retro
Autor:
Charlotte L. Barnett, Elaine Schertz, Dayu Lv, Daniel R. Cherñavvsky, Boris Kovatchev, Chiara Fabris, Stacey M. Anderson, Jessica Robic, Jennifer Pinnata, Mary C. Oliveri, Stephen D. Patek, Marc D. Breton, Christian A. Wakeman, Laura L. Kollar
Publikováno v:
Diabetes technologytherapeutics. 20(8)
Background: Glucose variability (GV) remains a key limiting factor in the success of diabetes management. While new technologies, for example, accurate continuous glucose monitoring (CGM) and connected insulin delivery devices, are now available, cur
Autor:
Chiara Dalla Man, Marc D. Breton, Michele Schiavon, Roberto Visentin, Boris Kovatchev, Martina Vettoretti, Enrique Campos-Náñez, Claudio Cobelli, Dayu Lv
Background: A new version of the UVA/Padova Type 1 Diabetes (T1D) Simulator is presented which provides a more realistic testing scenario. The upgrades to the previous simulator, which was accepted by the Food and Drug Administration in 2013, are des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4d3a8ebf7a3a562d2848398856c2ab
http://hdl.handle.net/11577/3258527
http://hdl.handle.net/11577/3258527
Autor:
Eyal, Dassau, Jordan E, Pinsker, Yogish C, Kudva, Sue A, Brown, Ravi, Gondhalekar, Chiara, Dalla Man, Steve, Patek, Michele, Schiavon, Vikash, Dadlani, Isuru, Dasanayake, Mei Mei, Church, Rickey E, Carter, Wendy C, Bevier, Lauren M, Huyett, Jonathan, Hughes, Stacey, Anderson, Dayu, Lv, Elaine, Schertz, Emma, Emory, Shelly K, McCrady-Spitzer, Tyler, Jean, Paige K, Bradley, Ling, Hinshaw, Alejandro J, Laguna Sanz, Ananda, Basu, Boris, Kovatchev, Claudio, Cobelli, Francis J, Doyle
Publikováno v:
Diabetes Care
OBJECTIVE Artificial pancreas (AP) systems are best positioned for optimal treatment of type 1 diabetes (T1D) and are currently being tested in outpatient clinical trials. Our consortium developed and tested a novel adaptive AP in an outpatient, sing
Publikováno v:
Diabetes Technology & Therapeutics. 15:935-941
Insulin-induced hypoglycemia is as a critical barrier in the treatment of type 1 diabetes mellitus patients and may lead to unconsciousness, brain damage, or even death. Clinically, glucagon is used as a rescue drug to treat severe hypoglycemic episo
Publikováno v:
Fuel. 90:1257-1263
The volume change of air microbubbles on surface nucleation sites was studied experimentally and compared with predictions. Measurements were used to determine the polytropic constant, the diffusion coefficient, and the Henry’s law constant of air
Publikováno v:
OBM Transplantation. 2:1-1
Human pancreatic islet transplantation is a minimally-invasive procedure that is gaining recognition for the treatment of type 1 diabetes (T1D). Selected patients with unstable T1D, hypoglycemia unawareness, history of severe hypoglycemia, and glycem
Autor:
Qian Zhang, Sandip D. Kulkarni, Dayu Lv, Stephen D. Patek, Colleen Hughes-Karvetski, Edward A. Ortiz, Marc D. Breton
Publikováno v:
Lecture Notes in Bioengineering ISBN: 9783319259116
Eating and exercise behaviors have an important effect on glycemic outcomes in type 1 diabetes, yet these influences are difficult to assess in real-life settings. While existing mathematical models faithfully represent the dynamic relationships of (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e7009573768b115aac0b7e538d84f3d
https://doi.org/10.1007/978-3-319-25913-0_8
https://doi.org/10.1007/978-3-319-25913-0_8